Detalhe da pesquisa
1.
Bone loss over time and risk of osteoporosis in advanced pancreatic cancer.
Jpn J Clin Oncol
; 54(6): 667-674, 2024 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38452123
2.
Clinical Efficacy of Neoadjuvant Chemotherapy with Gemcitabine plus S-1 for Resectable Pancreatic Ductal Adenocarcinoma Compared with Upfront Surgery.
Ann Surg Oncol
; 30(8): 5093-5102, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-37140750
3.
Prognostic impact of osteosarcopenia in patients with advanced pancreatic cancer receiving gemcitabine plus nab-paclitaxel.
Pancreatology
; 23(3): 275-282, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-36792473
4.
The impact of osteosarcopenia in patients with unresectable or recurrent biliary tract cancer receiving palliative chemotherapy.
Jpn J Clin Oncol
; 53(11): 1051-1057, 2023 Nov 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37554052
5.
Outcomes of lung oligometastasis in pancreatic cancer.
Jpn J Clin Oncol
; 53(12): 1144-1152, 2023 Dec 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37609670
6.
Long-term outcomes of duckbill-type anti-reflux metal stents versus conventional covered metal stents in reinterventions after covered biliary metal stent dysfunction in unresectable pancreatic cancer.
Surg Endosc
; 37(5): 3498-3506, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36581786
7.
Outcomes after partially covered self-expandable metal stent placement for recurrent duodenal obstruction.
Surg Endosc
; 37(1): 319-328, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35941307
8.
Analysis of prognostic factors for borderline resectable pancreatic cancer after neoadjuvant chemotherapy: the importance of CA19-9 decrease in patients with elevated pre-chemotherapy CA19-9 levels.
HPB (Oxford)
; 25(1): 100-108, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36280425
9.
KRAS variant allele frequency, but not mutation positivity, associates with survival of patients with pancreatic cancer.
Cancer Sci
; 113(9): 3097-3109, 2022 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-35567350
10.
Early-onset pancreatic cancer: Clinical characteristics and survival outcomes.
Pancreatology
; 22(4): 507-515, 2022 May.
Artigo
Inglês
| MEDLINE | ID: mdl-35422382
11.
Treatment outcomes of nanoliposomal irinotecan as second-line chemotherapy after gemcitabine and nab-paclitaxel in metastatic and recurrent pancreatic cancer.
Jpn J Clin Oncol
; 52(12): 1399-1407, 2022 Dec 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36111430
12.
Molecular Features and Clinical Management of Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer.
Int J Mol Sci
; 23(3)2022 Jan 21.
Artigo
Inglês
| MEDLINE | ID: mdl-35163129
13.
Improved prognosis of pancreatic cancer patients with peritoneal metastasis.
Pancreatology
; 21(5): 903-911, 2021 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-33766484
14.
The safety and efficacy of self-expandable metallic stent placement for malignant biliary obstruction with surgically altered anatomy.
Scand J Gastroenterol
; 56(1): 94-102, 2021 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-33198542
15.
The impact of body composition on short-term outcomes of neoadjuvant chemotherapy with gemcitabine plus S-1 in patients with resectable pancreatic cancer.
Jpn J Clin Oncol
; 51(4): 604-611, 2021 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33479765
16.
The prognostic impact of tumour location and first-line chemotherapy regimen in locally advanced pancreatic cancer.
Jpn J Clin Oncol
; 51(5): 728-736, 2021 Apr 30.
Artigo
Inglês
| MEDLINE | ID: mdl-33611490
17.
Treatment outcomes of erlotinib plus gemcitabine as late-line chemotherapy in unresectable pancreatic cancer.
Jpn J Clin Oncol
; 51(9): 1416-1422, 2021 Aug 30.
Artigo
Inglês
| MEDLINE | ID: mdl-34128055
18.
The impact of cachexia and sarcopenia in elderly pancreatic cancer patients receiving palliative chemotherapy.
Int J Clin Oncol
; 26(7): 1293-1303, 2021 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-33791917
19.
Risk factors for gemcitabine plus nab-paclitaxel-induced interstitial lung disease in pancreatic cancer patients.
Int J Clin Oncol
; 26(3): 543-551, 2021 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-33175298
20.
Efficacy and safety of sodium RISedronate for glucocorticoid-induced OsTeoporosis with rheumaTOid arthritis (RISOTTO study): A multicentre, double-blind, randomized, placebo-controlled trial.
Mod Rheumatol
; 31(3): 593-599, 2021 May.
Artigo
Inglês
| MEDLINE | ID: mdl-32820698